TRAJENTA DUO 2.5MG/850MG TABLET (Linagliptin Metformin) Guide
TRAJENTA DUO 2.5MG/850MG TABLET contains Linagliptin 2.5mg and Metformin 850mg, a combination antidiabetic medicine prescribed to improve blood sugar control in adults with Type 2 Diabetes.
TRAJENTA DUO 2.5MG/850MG TABLET
TRAJENTA DUO 2.5MG/850MG TABLET (Linagliptin 2.5mg + Metformin 850mg): Comprehensive Guide and Benefits
Introduction to TRAJENTA DUO 2.5MG/850MG TABLET
TRAJENTA DUO 2.5MG/850MG TABLET: DPP-4 Inhibitor + Biguanide Combination Antidiabetic Medicine
TRAJENTA DUO 2.5MG/850MG TABLET is a prescription Diabetes Medication containing Linagliptin 2.5mg and Metformin Hydrochloride 850mg. It belongs to the drug class Dipeptidyl Peptidase-4 (DPP-4) Inhibitor + Biguanide Combination Therapy and is prescribed along with diet and exercise to improve blood glucose control in adults with Type 2 Diabetes Mellitus when treatment with both medicines is appropriate. (National Drug Formulary)
TRAJENTA DUO combines two medicines with complementary actions. Linagliptin helps regulate insulin release through incretin hormone activity, while Metformin reduces glucose production in the liver and improves the body's response to insulin. (1mg)
Key Benefits of TRAJENTA DUO 2.5MG/850MG TABLET
Helps improve blood glucose control in adults with Type 2 Diabetes Mellitus.
Supports better fasting and post-meal blood sugar management.
Enhances glucose-dependent insulin release through incretin pathway support.
Helps reduce excess glucose production by the liver.
Improves insulin sensitivity for better glucose utilisation.
Provides convenient combination therapy in a single tablet. (1mg)
How TRAJENTA DUO 2.5MG/850MG TABLET Works
TRAJENTA DUO 2.5MG/850MG TABLET contains two active ingredients:
Linagliptin
Linagliptin is a DPP-4 inhibitor that blocks the enzyme Dipeptidyl Peptidase-4. This prevents the breakdown of incretin hormones such as GLP-1 and GIP, helping increase insulin release when blood glucose levels are elevated and reducing glucagon secretion.
Metformin
Metformin belongs to the Biguanide class of antidiabetic medicines. It primarily reduces glucose production in the liver, improves insulin sensitivity, and supports better glucose uptake by body tissues.
Together, these mechanisms help maintain improved blood glucose levels in patients with Type 2 Diabetes. (1mg)
Usage Instructions for TRAJENTA DUO 2.5MG/850MG TABLET
Take TRAJENTA DUO 2.5MG/850MG TABLET exactly as prescribed by your doctor.
Swallow the tablet whole with water.
Take it with or after food as advised to improve stomach tolerance. (1mg)
Do not crush, chew, or break the tablet unless instructed.
Maintain a balanced diet and regular exercise routine.
Do not stop or change the dose without medical advice.
Medicinal Advantages of TRAJENTA DUO 2.5MG/850MG TABLET
Provides dual-action glucose-lowering benefits.
Helps improve insulin response and glucose regulation.
Supports reduction of excessive liver glucose production.
Helps manage Type 2 Diabetes as part of a complete diabetes care plan.
Offers a convenient oral combination therapy option. (Apollo Pharmacy)
NOTE: TRAJENTA DUO 2.5MG/850MG TABLET is a prescription-only medicine. It should be used under medical supervision with regular monitoring of blood glucose levels and overall diabetes management. (National Drug Formulary)
Off-Label Uses of TRAJENTA DUO 2.5MG/850MG TABLET
Linagliptin and Metformin combinations may sometimes be evaluated for additional clinical applications based on specialist assessment and available evidence.
Possible physician-guided applications may include:
Individualised metabolic management strategies.
Specialist-directed glucose control approaches.
Supportive treatment plans for insulin resistance-related conditions.
Disclaimer: Off-label use should only be considered under qualified medical supervision.
Expert Advice for Optimal Use
Take TRAJENTA DUO regularly as prescribed.
Monitor blood glucose levels as advised by your healthcare provider.
Follow a diabetes-friendly diet and exercise routine.
Inform your doctor about kidney, liver, or pancreatic conditions.
Discuss all medicines and supplements being used.
Attend regular diabetes follow-up appointments.
Precautions
Cardiovascular Health
Patients with cardiovascular conditions should inform their doctor before starting treatment so therapy can be personalised according to their health status.
Liver & Kidney Function
Patients with kidney or liver disorders should consult their healthcare provider before use. Kidney function monitoring may be required because Metformin elimination depends on kidney function.
Pregnancy & Breastfeeding
Pregnant or breastfeeding women should use TRAJENTA DUO 2.5MG/850MG TABLET only after consulting a healthcare professional.
Drug Interactions
Inform your doctor about all prescription medicines, supplements, and herbal products being used, especially other diabetes medicines.
Existing Medical Conditions
Patients with kidney disease, dehydration, severe infections, or a history of pancreatic disorders should discuss their medical history before starting treatment.
Storage Instructions
Store below 30°C in a dry place. (1mg)
Keep tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep away from children.
Do not use after the expiry date.
Frequently Asked Questions (FAQs)
Q: What is TRAJENTA DUO 2.5MG/850MG TABLET used for?
A: TRAJENTA DUO 2.5MG/850MG TABLET is used to improve blood sugar control in adults with Type 2 Diabetes Mellitus along with diet and exercise. (1mg)
Q: What are the active ingredients in TRAJENTA DUO 2.5MG/850MG TABLET?
A: It contains Linagliptin 2.5mg and Metformin Hydrochloride 850mg. (National Drug Formulary)
Q: What type of medicine is TRAJENTA DUO 2.5MG/850MG TABLET?
A: It is a combination antidiabetic medicine containing a DPP-4 inhibitor and a Biguanide.
Q: How does TRAJENTA DUO work?
A: Linagliptin increases incretin hormone activity, while Metformin reduces liver glucose production and improves insulin sensitivity. (1mg)
Q: Can TRAJENTA DUO 2.5MG/850MG TABLET be stopped suddenly?
A: Do not stop this medicine without consulting your doctor, as blood sugar levels may become difficult to control.
Q: How should TRAJENTA DUO 2.5MG/850MG TABLET be taken?
A: It should be taken exactly as prescribed, usually with or after food, and swallowed whole with water. (1mg)
Product Tags
TRAJENTA DUO 2.5MG/850MG TABLET, TRAJENTA DUO TABLET, Linagliptin 2.5mg, Metformin 850mg, Linagliptin Metformin tablet, DPP-4 inhibitor medicine, Biguanide antidiabetic medicine, Type 2 diabetes medicine, blood sugar control tablet, oral diabetes medication, glucose management therapy, Boehringer Ingelheim TRAJENTA DUO, prescription diabetes medicine, diabetic care tablet, insulin sensitivity medicine, glycemic control therapy.
